Fairmount Funds Management LLC 的 Form 4 申報
Cogent Biosciences, Inc.（COGT），2026/3/31 申報
- 申報編號
- 0001104659-26-038057
- 申報時間
- 2026/3/31
- 交易日
- 2026/3/31
- 申報延遲
- 當天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 2 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $2.43 億。交易當天就申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Fairmount Funds Management LLCCIK 0001802528 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/3/31 | Common Stock | C轉換取得 | +7,000,000 | –F1 | – | 12,503,418 | 間接 | |
| 2026/3/31 | Common Stock | S賣出處分 | −7,000,000 | $34.66 | −$242,620,000 | 5,503,418 | 間接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/3/31 | Common Stock | C轉換處分 | −7,000,000 | $0.00 | $0 | 39,414 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Each share of Series A Convertible Preferred Stock is convertible into shares of Common Stock at any time at the option of the holder thereof, into 250 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series A Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 9.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. On March 31, 2026, the Reporting Persons converted 28,000 shares of Series A Convertible Preferred Stock into 7,000,000 shares of Common Stock for no cash consideration, in accordance with the Certificate of Designations for the Series A Convertible Preferred Stock.
表 I 有 1 筆交易的價格引用這則附註。
備註
This Form 4 is filed jointly with Fairmount Healthcare Fund II GP LLC. The Reporting Person may be deemed a director by deputization of Issuer by virtue of the fact that Peter Harwin serves on the board of directors of Issuer and is also a Managing Member of Fairmount Funds Management LLC.